Anti-VEGF-Anti-PD-l1 bispecific antibody, pharmaceutical composition of same and uses thereof
MYPI2026001176A0Undetermined Publication Date: 2022-02-28BIOTHEUS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026001176
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-08-31
- Filing Date
- 2021-08-30
- Publication Date
- 2022-02-28
Abstract
The present invention relates to the field of biomedicine and specifically relates to an anti-VEGF-anti-PD-L1 bispecific antibody, a pharmaceutical composition of same, and uses thereof. Specifically, the present invention relates to the bispecific antibody, which comprises: a VEGF-targeted first protein functional area and a PD-L1-targeted second protein functional area, wherein: the first protein functional area is an anti-VEGF antibody or an antigen-binding fragment thereof, or, the first protein functional area comprises a VEGF receptor or a fragment having a VEGF receptor function, and the second protein functional area is an anti-PD-L1 monoclonal antibody. The bispecific antibody of the present invention is capable of activating the immune system and blocking tumor angiogenesis at the same time, and provides great antitumor prospects. Figure 2.
Need to check novelty before this filing date? Find Prior Art
